Navigation Links
Sagent Pharmaceuticals Announces Launch of Adenosine Injection, USP, in 6 mg per 2 mL Single-Dose Vials
Date:9/1/2009

SCHAUMBURG, Ill., Sept. 1 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced the launch of adenosine injection, USP, an antiarrhythmic drug used to treat paroxysmal supraventricular tachycardia. Sagent will offer this latex-free, preservative-free adenosine product in 6 mg per 2 mL single-dose glass vials for intravenous use.

"This launch expands upon the full line of prefilled adenosine syringes we introduced in 2007, providing caregivers an array of adenosine delivery options in cardiac care settings," said Jeffrey M. Yordon, chief executive officer, founder, and chairman of the board of Sagent. "Our 2 mL adenosine vial is the second product introduced from our collaboration with Strides Arcolab."

Sagent and Strides Arcolab are jointly developing, supplying and marketing more than 25 injectable products for the U.S. market.

About Adenosine Injection, USP

Adenosine Injection, USP, is the generic equivalent of Astellas Pharma U.S., Inc.'s Adenocard(R), an antiarrhythmic commonly used in the treatment of paroxysmal supraventricular tachycardia, a rhythm disturbance of the heart, in critical care situations. Adenosine works by slowing the electrical conduction in the heart, slowing heart rate of normalizing heart rhythm.

Adenosine injection does not convert atrial flutter, atrial fibrillation, or ventricular tachycardia to normal sinus rhythm. In the presence of atrial flutter or atrial fibrillation, a transient modest slowing of ventricular response may occur immediately following adenosine administration.

The package insert, which is available at www.SagentPharma.com, contains detailed information about the indication, complete side effect profile and prescribing information.

About Sagent Pharmaceuticals, Inc.<
'/>"/>

SOURCE Sagent Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. ISTA Pharmaceuticals Announces Positive Preliminary Phase 3 Clinical Results to Support sNDA Filing for Once-Daily Xibrom(TM) 0.09%
2. NovaBay Pharmaceuticals to Present New Data on Lead Anti-Infective Compound at the 2009 ICAAC Annual Meeting
3. Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease
4. Amira Pharmaceuticals Submits IND for Second DP2 Antagonist, AM461
5. Adamas Pharmaceuticals Signs CRADA With U.S. Navy to Conduct Preclinical Studies of Triple-Combination Antiviral Drug Therapy for Influenza A, Including the Novel H1N1 Pandemic Strain
6. Eiger BioPharmaceuticals Announces Initiation of CLEAN-1 HCV Phase 1b Trial
7. Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program
8. Poniard Pharmaceuticals Announces Positive Cardiac Safety Data From Picoplatin Phase 1 Trial Supporting NDA Filing
9. Idenix Pharmaceuticals Successfully Completes Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV)
10. Cardax Pharmaceuticals Nominates Clinical Candidate Heptax for Liver Disease; Heptax Ameliorates Inflammation and Oxidative Stress Related to Liver Disease and Metabolic Syndrome
11. BioCryst Pharmaceuticals Reports Positive Results of Shionogi & Co. Sponsored Phase 3 Studies of i.v. Peramivir for Influenza
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... SANTA CLARA, Calif. , June 19, 2013 ... and control solutions for life sciences process applications, ... 3L glass bioreactors for upstream cell culture and ... in a new product family of Finesse bioreactors ... R&D and cGMP applications.  They are fully compatible ...
(Date:6/19/2013)... June 19, 2013 /PRNewswire/ -- Chindex International, Inc. (NASDAQ: ... company providing services in China ... a network of private hospitals and affiliated ambulatory ... Beijing United Family Rehabilitation Hospital ("BJU Rehab Hospital"), ... United Family Healthcare ("UFH") network. On June 19, ...
(Date:6/19/2013)... NESS ZIONA, Israel , ... today announced that results from a phase I study ... study in advanced Parkinson,s patients, of ND0612, were presented ... Movement Disorders. ND0612 is a proprietary levodopa/carbidopa liquid drug ... (SC) delivery patch that would maintain constant levodopa plasma ...
Breaking Medicine Technology:Finesse Solutions Launches Next Generation SmartGlass 3L Bioreactors for Cell Culture and Fermentation 2Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 2Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 3Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 4Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 5NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 2NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 3NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 4NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 5NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 6
...  Based on its recent analysis of the neuro-psychiatric ... the 2012 Global Frost & Sullivan New Product ... (dTMS) is the only non-invasive technique that can ... other neuro-psychiatric disorders without causing any significant side ...
... adults suffering from visual impairment due to autism, brain injury, ... help from a revolutionary new therapy program using specially designed ... Oculomotor Therapy Program uses a web-based application in ... treat visual system dysfunction and strengthen visual skills. The application ...
Cached Medicine Technology:Frost & Sullivan New Product Innovation Award Presented to Brainsway for Its Deep Transcranial Magnetic Stimulation (dTMS) Device 2Frost & Sullivan New Product Innovation Award Presented to Brainsway for Its Deep Transcranial Magnetic Stimulation (dTMS) Device 3New Therapy Program Allows Doctors to Prescribe Computer Games on iPad to Treat Visual Impairment 2
(Date:6/20/2013)... June 20, 2013 Creighton University ... Community Service Honor Roll – the highest federal recognition ... to volunteering, student- service learning and civic engagement as ... by the Corporation for National and Community Service, is ... for Creighton. “Our foundation at Creighton is based on ...
(Date:6/19/2013)... Everyone is looking for ways to improve general ... do so. It is called Skin Brushing . Skin Brushing ... per day - to improve health and skin quality. It ... How? , Skin Brushing improves general health because:, , ... lymphatic system to drain toxins , it clears skins ...
(Date:6/19/2013)... Shreya Rangarajan of Roland Park Country ... on the future of medicine. , Today, Brandeis ... Summit on the Future of Medicine and has selected ... the state of Maryland at the Summit. , "The ... an environment hard to imagine just a few years ...
(Date:6/19/2013)... Conn (PRWEB) June 20, 2013 A man returning ... man he used to be. In his debut book titled RED ... war veteran who immerses himself back home, looking for the right ... Gabriel De Los Angeles, former marine from the Vietnam War, returns ... take the edge off his PTSD. Wings, a wealthy acquaintance from ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 According ... clinics, excessive sun exposure is perhaps the ... skin cancer, but that is just one of ... development of skin cancer. Other risk factors include:, ...     Radiation treatment ,     Heredity may play ...
Breaking Medicine News(10 mins):Health News:Creighton Again Named to President’s Honor Roll - University Picks Up Sixth Recognition Award for Service 2Health News:Creighton Again Named to President’s Honor Roll - University Picks Up Sixth Recognition Award for Service 3Health News:A Fast and Fun Way to Better Skin Quality and Overall Health, says Sublime Beauty® 2Health News:Global Youth Summit on The Future of Medicine-Shreya Rangarajan selected to represent Roland Park Country School and The State of Maryland 2Health News:Global Youth Summit on The Future of Medicine-Shreya Rangarajan selected to represent Roland Park Country School and The State of Maryland 3Health News:Rafael Fragauda’s New Book Underlines Post Traumatic Stress Disorder 2Health News:Risk Factors of Skin Cancer & Reducing That Risk 2Health News:Risk Factors of Skin Cancer & Reducing That Risk 3
... ... is introducing improved technology from HOYA ConBio® to make laser tattoo removal potentially quicker with ... (PRWEB) ... a practice devoted solely to laser tattoo removal since 1999. The RevLite ND:YAG ...
... , ... source for ultrasound, has revamped its brand, releasing an updated logo and a brand new ... wide web. , ... 12, 2010 -- MedCorp LLC, The Direct Source for Ultrasound, announces its new branding and ...
... ... Children,s hospital adopts single port technique for gynaecological procedures, raising the bar for minimally ... ... are taking minimally invasive surgery to new heights with the introduction of ...
... ... pharmaceutical promotion shifting away from print advertising toward electronic promotion for marketing to both ... ... and analytics firm, today reports evidence of pharmaceutical promotion shifting away from print advertising ...
... child deaths, according to a new study published today ... Health Organization (WHO) and UNICEF,s Child Health Epidemiology Reference ... estimates by country, region and the world. While the ... decade, the analysis reveals how millions of children under ...
... to infectious diseases, researchers report , TUESDAY, May 11 ... malaria and blood poisoning account for more than two-thirds ... 5 years of age worldwide, a new report shows. ... birth complications, lack of oxygen during birth and congenital ...
Cached Medicine News:Health News:Tattoo Removal Laser Clinic Announces New PhotoAcoustic Laser Technology 2Health News:Tattoo Removal Laser Clinic Announces New PhotoAcoustic Laser Technology 3Health News:MedCorp LLC Unveils New Marketing Campaign Including Refreshed Logo and All-New Website Focused on Ultrasound 2Health News:Singapore's Gynaecologists Break New Grounds 2Health News:Singapore's Gynaecologists Break New Grounds 3Health News:Singapore's Gynaecologists Break New Grounds 4Health News:SDI Reports: Pharmaceutical Promotion Spending Indicates Trend Toward Electronic and Online Promotion 2Health News:Infectious diseases caused two-thirds of the nearly 9 million child deaths globally in 2008 2Health News:Almost Half of Deaths in Kids Under 5 Occur in 5 Countries 2
Electric Reciprocating Saw, with hand throttle. Can also be purchased without hand throttle (#1915) for use with foot pedal. (#6401-000)...
... with hand throttle, 30,000 RPM, ... medium bur guard included, long ... guards are also available. Can ... throttle (#1940) for use with ...
... E9000® System is a specialized electric ... specifically designed for use in Otolaryngology, ... E9000 System consists of a specialized ... handpieces designed to provide precision and ...
... Micro Sagittal Saw, with hand ... arc. Head rotates 360 deg. ... and our unique blade locking ... also be purchased without hand ...
Medicine Products: